Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: A unique and effective approach to coronary artery thrombolysis
- 31 August 1991
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 18 (2) , 613-620
- https://doi.org/10.1016/0735-1097(91)90621-f
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining techniquePublished by Elsevier ,2004
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Myocardial protection via coronary sinus interventions: superior effects of arterialization compared with intermittent occlusion.Circulation, 1985
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase In Myocardial Infarction Trial.Circulation, 1984
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator.Circulation, 1984
- Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.Circulation, 1981